CUSTOMS COMPLIANCE | 2026-08-11
Section 232 Pharmaceutical Tariffs: CBP Filing Rules for 2026
Proclamation 11020 imposes a default 100 percent Section 232 duty on imports of patented pharmaceuticals, biologics, and their active ingredients, and CBP guidance now requires California importers to report new Chapter 99 classifications on every covered entry as the first duties take effect on July 31, 2026.
By Anatolii Trembach, Esq. (California State Bar No. 349304; LL.M., USC Gould School of Law; admitted to the U.S. Court of International Trade), Trembach Law Firm, APC · Published
Proclamation 11020, signed April 2, 2026 under Section 232, imposes a default 100 percent duty on imports of patented pharmaceuticals, biologics, and their active ingredients. CBP guidance CSMS 69395344 now requires California importers to report new Chapter 99 classifications on every covered entry as the first duties take effect July 31, 2026.
Contact Trembach Law Firm at (818) 514-7680 for a confidential consultation.
Trembach Law Firm | 27001 Agoura Road, Suite 350, Calabasas, CA 91301